Bevacizumab-induced laryngeal necrosis

D. M. Hartl; R. Bahleda; A. Hollebecque; J. Bosq; C. Massard; J. C. Soria

doi:10.1093/annonc/mdr515

Bevacizumab-induced laryngeal necrosis

D. M. Hartl, R. Bahleda, A. Hollebecque, J. Bosq, C. Massard, J. C. Soria

Research output: Contribution to journal › Letter › peer-review

14 Citations (Scopus)

Original language	English
Article number	mdr515
Pages (from-to)	276-278
Number of pages	3
Journal	Annals of Oncology
Volume	23
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdr515
Publication status	Published - 1 Jan 2012

Access to Document

10.1093/annonc/mdr515

Cite this

@article{5afc6ffab2264c7fabdc2a984eb41ad5,

title = "Bevacizumab-induced laryngeal necrosis",

author = "Hartl, {D. M.} and R. Bahleda and A. Hollebecque and J. Bosq and C. Massard and Soria, {J. C.}",

year = "2012",

month = jan,

day = "1",

doi = "10.1093/annonc/mdr515",

language = "English",

volume = "23",

pages = "276--278",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "1",

}

TY - JOUR

T1 - Bevacizumab-induced laryngeal necrosis

AU - Hartl, D. M.

AU - Bahleda, R.

AU - Hollebecque, A.

AU - Bosq, J.

AU - Massard, C.

AU - Soria, J. C.

PY - 2012/1/1

Y1 - 2012/1/1

UR - http://www.scopus.com/inward/record.url?scp=84855179986&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdr515

DO - 10.1093/annonc/mdr515

M3 - Letter

C2 - 22056850

AN - SCOPUS:84855179986

SN - 0923-7534

VL - 23

SP - 276

EP - 278

JO - Annals of Oncology

JF - Annals of Oncology

IS - 1

M1 - mdr515

ER -

Bevacizumab-induced laryngeal necrosis

Access to Document

Other files and links

Cite this